This place is fantastic
Along with strong GH release, it produces significant appetite stimulation through ghrelin receptor activation, mild to moderate cortisol and prolactin elevation, and the most intense hunger response of any peptide in this class
The Pasqua et al
Storage: Store tightly sealed in a cool, dry place
In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
Food and Drug Administration (FDA) announced a semaglutide warning label update on September 22, 2023, warning that Ozempics warning label would be updated to include certain gastrointestinal side effects on September 22, 2023